New Human Medicines: RSS Feed from EMA
- Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
- Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Enwylma, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
- Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Status: Opinion
- Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Status: Opinion
- Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Status: Opinion
- Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Status: Opinion
MedWatch Safety Alert RSS Feed
- Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
- Risk of False Positive Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
- Early Alert: Intravascular PICC Catheter Issue from BD
- Early Alert: Diagnostic Intravascular Catheter Issue from Conavi
- Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter
- FDA Classifies Q’Apel Medical Inc.’s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
- Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses in the U.S.
- Max Mobility / Permobil Expands Nationwide Recall of SmartDrive Speed Control Dial Due to the Motor Being Unresponsive to the User
- Update: Potential Risk of Exposure to Toxic Compounds When Using Hemodialysis and Peritoneal Dialysis Systems - Letter to Health Care Providers
- Peritoneal Dialysis Set Correction: Baxter Issues Correction for MiniCap Extended Life Peritoneal Dialysis Transfer Sets Due to Risk of Patient Exposure to Higher Than Allowable Levels of Toxic Compound NDL-PCBA and/or NDL-PCBs